
Understanding This Year’s Major Medicare Changes
TL/DR –
Around 70 million U.S. seniors on Medicare will face significant changes in 2026. Significant changes include a 9.7% rise in Medicare Part B premiums, the introduction of a prior authorization pilot, and a 2.48% increase in Medicare Advantage reimbursement rates. Furthermore, the Inflation Reduction Act of 2022 has allowed for the negotiation of medication prices, resulting in cost reductions of up to 79% for ten Medicare Part D drugs.
“`html
Significant Changes Expected for Medicare in 2026
With approximately 70 million seniors in the United States relying on Medicare, significant changes expected in 2026 could significantly affect recipients. This may have considerable implications for your personal financial situation.
Understanding Medicare
Medicare serves as the national health insurance program for seniors, providing coverage for those who are 65 and older, and some younger individuals who qualify due to disability. It covers a large portion of medical services expenses, but beneficiaries still bear certain out-of-pocket costs such as premiums, deductibles, copayments, and coinsurance. The program is divided into four parts:
- Part A – Hospital insurance
- Part B – Health insurance
- Part C – Medicare Advantage, an alternative to Original Medicare
- Part D – Prescription drug coverage
Rise in Premiums
In 2026, Medicare Part B premiums are forecasted to rise by 9.7%, resulting in a monthly cost of $202.90. This increase is attributed to a predicted surge in healthcare spending, with some experts foreseeing an additional rise in premium costs for 2027.
Lower Drug Prices through Negotiation
The Inflation Reduction Act of 2022 mandated the Department of Health and Human Services to negotiate the cost of certain drugs with the manufacturing companies. For 2026, 10 drugs under Medicare Part D have been selected for negotiation, leading to price reductions by up to 79%. The list of these medication includes some for treating cancer, Type 2 diabetes, and kidney disease.
Extension of Telehealth Services
Medicare beneficiaries will continue to have telehealth services coverage through Dec. 31, 2027. The services cover care in their homes, excluding mental or behavioral health issues. Those living in rural areas are permanently eligible for telehealth services for mental or behavioral health issues.
Prior Authorization Pilot Introduction
An estimated 6.4 million Medicare beneficiaries will need to obtain prior approval before Original Medicare covers the cost of some supplies, services, and equipment under a new pilot program. Some groups have raised concerns that these changes might result in the denial or delay of services to some Medicare beneficiaries.
Increase in Medicare Advantage Reimbursement Rates
The U.S. Centers for Medicare & Medicaid Services has finalized a 2.48% reimbursement rate increase for 2027 Medicare Advantage plans. Critics call this a “gift to insurers,” as the government initially planned a smaller 0.09% increase. However, CMS argues that this move is necessary to keep Medicare Advantage and Part D coverage affordable.
Price Reduction for More Drugs in 2027
In 2027, an additional 15 drugs will be added to the list of those receiving negotiated price reductions. These include drugs for weight loss and management of Type 2 diabetes, cardiovascular disease, and more.
Upcoming Open Enrollment
With a deeper understanding of the upcoming changes to Medicare, it may be necessary to find a new plan that suits your current needs. Open enrollment is scheduled to take place from Oct. 15 through Dec. 7, offering the perfect opportunity to explore new Medicare plans.
Assistance for Medicare
Understanding Medicare can be challenging, and changes only add to the complexity. Fortunately, assistance is available from the State Health Insurance Assistance Program (SHIP) that offers free Medicare guidance.
Conclusion
Medicare continually evolves, and 2026 will be no different. It’s crucial to understand these changes to adjust adequately and minimize financial stress.
“`
—
Read More US Economic News